Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction

Expressions and clinical implications of cancer-testis antigen (CTA) lactate dehydrogenase (LDH)-C4 in hepatocellular carcinoma (HCC) have not been fully elucidated. Herein, expressions of LDHC mRNA in the serum and serum-derived exosomes of early-stage HCC patients were determined using qRT-PCR, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Zhaolei, Li, Yun, Gao, Yanni, Kong, Lingying, Lin, Yingfeng, Chen, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732326/
https://www.ncbi.nlm.nih.gov/pubmed/33035196
http://dx.doi.org/10.18632/aging.103879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732326/
https://www.ncbi.nlm.nih.gov/pubmed/33035196
http://dx.doi.org/10.18632/aging.103879

Ejemplares similares